AG003AX8

548-73-2 | Droperidol

Chemical structure of Droperidol, CAS 548-73-2
AG003AX8
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 548-73-2
Catalog Number AG003AX8(AGN-PC-0SI537)
Chemical Name Droperidol
EC Number 208-957-8
IUPAC Name 3-[1-[4-(4-fluorophenyl)-4-oxobutyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one
InChI InChI=1S/C22H22FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-11H,3,6,12-15H2,(H,24,28)
InChI Key RMEDXOLNCUSCGS-UHFFFAOYSA-N
MDL Number MFCD00083290
Molecular Formula C22H22FN3O2
Molecular Weight 379.4274
SMILES FC1=CC=C(C=C1)C(CCCN1CCC(=CC1)N1C(NC2=C1C=CC=C2)=O)=O
UNII O9U0F09D5X
Synonyms
Dehidrobenzperidol, Dehydrobenzperidol, Droleptan, Droperidol, Inapsine, droperidol, 548-73-2, Droleptan, Inapsine, Dehydrobenzperidol, Dridol, Properidol, Sintodril, Sintosian, Inapsin, Vetkalm, Halkan, Deidrobenzperidolo, DHBP, Inopsin, Innovar, Droperidolum, Inappin, Innovan, McN-JR-4749, Inoval, Dehidrobenzperidol, Droperidolo, Leptofen, Thalamanol, Thalamonal, Innovar-vet, Dihidrobenzperidol, Dehydrobenzoperidol, Droperidolo [DCIT], R-4749, McN-JR 4749, Droperidolum [INN-Latin], component of Innovar, R 4749, NSC 169874, UNII-O9U0F09D5X, CCRIS 9070, C22H22FN3O2, HSDB 3320, R4749, 1-(1-(3-(p-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone, 1-(1-(4-(p-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone, EINECS 208-957-8, BRN 0579168, CHEMBL1108, 1-[1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone, MLS000028671, CHEBI:4717, O9U0F09D5X, 2H-Benzimidazol-2-one, 1-[1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl]-1,3-dihydro-, RMEDXOLNCUSCGS-UHFFFAOYSA-N, MFCD00083290, NSC169874, 3-[1-[4-(4-fluorophenyl)-4-oxobutyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one, 1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydropyridin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one, 2H-Benzimidazol-2-one, 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridinyl)-1,3-dihydro-, NCGC00016504-01, CAS-548-73-2, SMR000058855, DSSTox_CID_2973, DSSTox_RID_76811, DSSTox_GSID_22973, 1-{1-[4-(4-Fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one, W-105600, Neurolidol, Ina.psi.ne, Ina.psi.n, Ino.psi.n, 1-[1-[4-(p-Fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone, 2-Benzimidazolinone, 1-(1-(3-(p-fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-, 2-Benzimidazolinone, 1-[1-[3-(p-fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl]-, 3-[1-[4-(4-fluorophenyl)-4-oxo-butyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one, Droleptan (TN), 1-(1-(4-(4-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridinyl)-1,3-dihydro-2H-benzimidazol-2-one, 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one, 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridin-4-yl)-1H-benzo[d]imidazol-2(3H)-one, 1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[d]imidazol-2-one, Droperidol [USAN:INN:BAN:JAN], SR-05000001546, INAPSINE (TN), Droperidol USP, 1-(1-[3-(p-fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone, 1-[1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl]-1,3-dihydro-2h-benzimidazol-2-one, Prestwick_705, Innovar (Salt/Mix), Droperidol [USAN:USP:INN:BAN:JAN], HS-0065, Leptanal (Salt/Mix), Leptofen (Salt/Mix), Spectrum_001220, Thalamonal (Salt/Mix), AC1L1FBQ, Innovar-vet (Salt/Mix), Opera_ID_1751, Prestwick0_000360, Prestwick1_000360, Prestwick2_000360, Prestwick3_000360, Spectrum2_001386, Spectrum3_001426, Spectrum4_000407, Spectrum5_001305, SCHEMBL41426, BSPBio_000459, BSPBio_003132, KBioGR_000674, KBioSS_001700, 5-24-02-00388 (Beilstein Handbook Reference), MLS000758203, MLS001148120, MLS001424134, MLS002153445, DivK1c_000103, SPECTRUM1501002, SPBio_001372, SPBio_002380, BPBio1_000505, Droperidol (JP17/USP/INN), GTPL7172, DTXSID6022973, CTK7B9727, CTK8F9380, HMS500F05, KBio1_000103, KBio2_001700, KBio2_004268, KBio2_006836, KBio3_002352, KS-00000XNO, NINDS_000103, HMS1569G21, HMS1921B03, HMS2051L06, HMS2092O16, HMS2096G21, HMS2232M09, HMS3374B05, HMS3393L06, HMS3652M12, HMS3713G21, Pharmakon1600-01501002, HY-B1240, Tox21_110461, BDBM50017705, CCG-39004, NSC757819, s4096, STL453109, ZINC19796080, AKOS015960779, Tox21_110461_1, AC-3537, CCG-101004, CS-4886, DB00450, NC00254, NSC-169874, NSC-757819, VA10777, 1-1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl-2-benzimidazolinone, IDI1_000103, NCGC00016504-02, NCGC00016504-03, NCGC00016504-04, NCGC00016504-05, NCGC00016504-06, NCGC00016504-09, NCGC00016504-17, NCGC00094884-01, NCGC00094884-02, AN-12875, BC204193, CPD000058855, H920, LS-33253, SAM001247013, SBI-0051628.P002, Droperidol 1.0 mg/ml in Dimethyl Sulfoxide, AK00094085, FT-0655846, SW220019-1, D00308, AB00052191_04, AB00052191_05, WLN: T56 BMVNJ D3- DT6N CUTJ A3VR DF, 548D732, A830387, C-55183, L001006, I14-2728, SR-05000001546-1, SR-05000001546-2, SR-05000001546-3, BRD-K97158071-001-05-8, BRD-K97158071-001-08-2, Droperidol, British Pharmacopoeia (BP) Reference Standard, Droperidol, European Pharmacopoeia (EP) Reference Standard, Droperidol, United States Pharmacopeia (USP) Reference Standard, 2H-Benzimidazol-2-one,2,3,6-tetrahydro-4-pyridinyl]-1,3-dihydro-, 1-[1-[3-(p-Fluorobenzoyl)propyl]-1,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone, 1-[1-[4-(p-Fluorophenyl)-4-oxobutyl]-1,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone, 1-1-[3-(p-Fluorobenzoyl)propyl]-1,3,6-tetrahydro-4-pyridyl-2-benzimidazolinone, 2H-Pyrrolo[3,2-b]pyridin-2-one, 1,3-dihydro-3-[(1-methyl-1H-indol-3-yl)methylene]-, gamma-[4-(2-oxo-1-benzimidazolinyl)-1,2,3,6-tetrahydro-1-pyridyl]-p-fluorobutyrophenone, 1-(4-fluorophenyl)-4-[4-(2-hydroxy-1H-1,3-benzodiazol-1-yl)-1,2,3,6-tetrahydropyridin-1-yl]butan-1-one, 1-(4-fluorophenyl)-4-[4-(2-hydroxy-1h-benzimidazol-1-yl)-3,6-dihydropyridin-1(2h)-yl]butan-1-one, 1-[1-[4-(4-fluorophenyl)-4-oxo-butyl]-3,6-dihydro-2H-pyridin-4-yl]-3H-benzoimidazol-2-one, 1-{1-[4-(4-Chloro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one(Droperidol), 1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydropyridin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one, 2H-Benzimidazol-2-one,1-[1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl]-1,3-dihydro-, 3-[1-[4-(4-fluorophenyl)-4-oxidanylidene-butyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one, Leptanal, Mixture Name, Dropletan (TN), Dridol (TN), Kern Brand of Droperidol, D03CJL, Taylor Brand of Droperidol, Janssen Brand of Droperidol, Droperidol (JP15/USP/INN), CID3168, Droperidol [USAN:BAN:INN:JAN], C22-H22-F-N3-O2, FENTANYL CITRATE AND DROPERIDOL, CS-T-21406, GW441756, 1-[1-[4-(p-F, B1736, 2-Benzimidazolinone, 1-[1-[3-(p-fluorobenz, D004329, 2-Benzimidazolinone,2,3,6-tetrahydro-4-pyridyl]-, luorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone, 1-(1-[4-FLUOROBENZOYLPROPYL]-1,2,3,6-TETRAHYDRO-4-PYRIDYL)-2-BENZIMIDAZOL, 504433-23-2,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited